Runny Nose During Pregnancy Page

The primary drivers of a runny nose during pregnancy are hormonal, with estrogen and progesterone playing leading roles. These hormones, whose levels rise exponentially during gestation, directly affect the nasal mucosa. Estrogen increases blood flow to the mucous membranes and stimulates the production of mucus from goblet cells. Simultaneously, progesterone causes vasodilation and relaxation of smooth muscle, leading to engorgement of the venous sinuses within the nasal turbinates. The result is a cascade of effects: swollen, pale, and boggy nasal tissues that produce an excess of clear, watery discharge. This is not an allergic reaction or an infection; it is a direct pharmacological effect of the pregnancy endocrine environment. Consequently, the classic symptoms—nasal congestion, sneezing, and postnasal drip—often emerge around the second month of gestation and may persist or even intensify until delivery, resolving completely within two weeks postpartum.

The management of a runny nose during pregnancy requires a cautious, evidence-based approach, as the safety of the developing fetus is paramount. Fortunately, the first-line treatments are non-pharmacological and highly effective. Simple elevation of the head during sleep using an extra pillow can reduce venous pooling in the nasal passages. The use of a cool-mist humidifier or saline nasal irrigation (using a neti pot or squeeze bottle with sterile water or saline) is exceptionally safe and helps to thin mucus and clear irritants. Nasal saline sprays can be used liberally. If these measures fail, clinicians may consider intranasal medications, which act locally and have minimal systemic absorption. Intranasal cromolyn sodium is considered safe for use during pregnancy. For more severe congestion, intranasal corticosteroids (e.g., budesonide) are the preferred pharmacological option, with extensive safety data supporting their use. In contrast, oral decongestants like pseudoephedrine should be used with extreme caution, particularly in the first trimester, due to potential associations with rare birth defects and concerns about vasoconstriction that could affect placental blood flow. Topical decongestant sprays (e.g., oxymetazoline) are generally avoided due to the risk of rebound congestion (rhinitis medicamentosa) and potential systemic effects. runny nose during pregnancy

Distinguishing rhinitis of pregnancy from other causes of a runny nose is a critical clinical task. The pregnant patient is not immune to the common viral infections that circulate in the community. However, several key features help differentiate the two. Unlike the common cold, which typically lasts seven to ten days and is often accompanied by sore throat, cough, low-grade fever, and systemic fatigue, rhinitis of pregnancy is chronic, lasting weeks or months. The nasal discharge is typically clear and watery, whereas a cold often progresses to thick, yellow or green mucus. Furthermore, the condition is bilateral and non-seasonal, unlike allergic rhinitis, which is triggered by specific allergens like pollen or dust and often accompanied by itchy eyes and sneezing paroxysms. A careful history—noting the timing of symptom onset relative to the pregnancy, the absence of infectious signs, and the lack of response to typical antihistamines—usually provides the diagnosis. The primary drivers of a runny nose during